{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:12:20Z","timestamp":1791245540285,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88969-3","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:15:41Z","timestamp":1738818941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dietary and lifestyle indices for hyperinsulinemia and odds of MAFLD in overweight and obese children and adolescents"],"prefix":"10.1038","volume":"15","author":[{"given":"Ali","family":"Nikparast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmis","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooneh","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Amani Farani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golaleh","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"88969_CR1","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/S0140-6736(14)61746-3","volume":"385","author":"T Lobstein","year":"2015","unstructured":"Lobstein, T. et al. Child and adolescent obesity: part of a bigger picture. Lancet 385, 2510\u20132520 (2015).","journal-title":"Lancet"},{"key":"88969_CR2","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.51745\/najfnr.4.9.S63-S74","volume":"4","author":"HN Ene-Obong","year":"2020","unstructured":"Ene-Obong, H. N., Alozie, Y., Abubakar, S., Aburime, L. & Leshi, O. O. Update of the nutrition situation in Nigeria. North. Afr. J. Food Nutr. Res. 4, S63\u2013S74 (2020).","journal-title":"North. Afr. J. Food Nutr. Res."},{"key":"88969_CR3","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Global prevalence of overweight and obesity in children and adolescents: a systematic review and Meta-analysis. JAMA Pediatr. (2024).","DOI":"10.1001\/jamapediatrics.2024.1576"},{"key":"88969_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/obr.12535","volume":"18","author":"YH Quek","year":"2017","unstructured":"Quek, Y. H., Tam, W. W., Zhang, M. W. & Ho, R. C. Exploring the association between childhood and adolescent obesity and depression: a meta-analysis. Obes. Rev. 18, 742\u2013754 (2017).","journal-title":"Obes. Rev."},{"key":"88969_CR5","doi-asserted-by":"crossref","unstructured":"Rankin, J. et al. Psychological consequences of childhood obesity: psychiatric comorbidity and prevention. Adolesc. Health Med. Ther., 125\u2013146 (2016).","DOI":"10.2147\/AHMT.S101631"},{"key":"88969_CR6","doi-asserted-by":"crossref","unstructured":"Friedemann, C. et al. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ 345 (2012).","DOI":"10.1136\/bmj.e4759"},{"key":"88969_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/children4060048","volume":"4","author":"H Bush","year":"2017","unstructured":"Bush, H., Golabi, P. & Younossi, Z. M. Pediatric non-alcoholic fatty liver disease. Children 4, 48 (2017).","journal-title":"Children"},{"key":"88969_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrgastro.2011.273","volume":"9","author":"A Alisi","year":"2012","unstructured":"Alisi, A., Feldstein, A. E., Villani, A., Raponi, M. & Nobili, V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat. Reviews Gastroenterol. Hepatol. 9, 152\u2013161 (2012).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"key":"88969_CR9","doi-asserted-by":"publisher","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","volume":"10","author":"EL Anderson","year":"2015","unstructured":"Anderson, E. L. et al. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PloS One. 10, e0140908 (2015).","journal-title":"PloS One"},{"key":"88969_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J. Hepatol. 73, 202\u2013209 (2020).","journal-title":"J. Hepatol."},{"key":"88969_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam, M. et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol. Hepatol. 6, 864\u2013873 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"88969_CR12","first-page":"972","volume":"9","author":"H Lin","year":"2021","unstructured":"Lin, H., Zhang, X., Li, G., Wong, G. L. H. & Wong, V. W. S. Epidemiology and clinical outcomes of metabolic (dysfunction)-associated fatty liver disease. J. Clin. Translational Hepatol. 9, 972 (2021).","journal-title":"J. Clin. Translational Hepatol."},{"key":"88969_CR13","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.3350\/cmh.2022.0364","volume":"29","author":"G Semmler","year":"2023","unstructured":"Semmler, G., Datz, C. & Trauner, M. Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease. Clin. Mol. Hepatol. 29, S244 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"88969_CR14","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.3390\/nu5104093","volume":"5","author":"BA Conlon","year":"2013","unstructured":"Conlon, B. A., Beasley, J. M., Aebersold, K., Jhangiani, S. S. & Wylie-Rosett, J. Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients 5, 4093\u20134114 (2013).","journal-title":"Nutrients"},{"key":"88969_CR15","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.3390\/nu14214505","volume":"14","author":"T Tian","year":"2022","unstructured":"Tian, T. et al. Dietary Quality and relationships with Metabolic Dysfunction-Associated fatty liver Disease (MAFLD) among United States adults, results from NHANES 2017\u20132018. Nutrients 14, 4505 (2022).","journal-title":"Nutrients"},{"key":"88969_CR16","doi-asserted-by":"publisher","first-page":"102063","DOI":"10.1016\/j.clinre.2022.102063","volume":"47","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. Metabolic-associated fatty liver disease and the risk of cardiovascular disease. Clin. Res. Hepatol. Gastroenterol. 47, 102063 (2023).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"88969_CR17","unstructured":"Harrison, S. A., Dubourg, J., Knott, M. & Colca, J. Hyperinsulinemia, an overlooked clue and potential way forward in metabolic dysfunction\u2013associated steatotic liver disease. Hepatology (9900)."},{"key":"88969_CR18","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158, 1999\u20132014 (2020).","journal-title":"Gastroenterology"},{"key":"88969_CR19","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1017\/S0007114516003755","volume":"116","author":"FK Tabung","year":"2016","unstructured":"Tabung, F. K. et al. Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle. Br. J. Nutr. 116, 1787\u20131798 (2016).","journal-title":"Br. J. Nutr."},{"key":"88969_CR20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/jn\/nxy319","volume":"149","author":"FK Tabung","year":"2019","unstructured":"Tabung, F. K., Satija, A., Fung, T. T., Clinton, S. K. & Giovannucci, E. L. Long-term change in both Dietary Insulinemic and Inflammatory potential is Associated with Weight Gain in Adult women and men. J. Nutr. 149, 804\u2013815. https:\/\/doi.org\/10.1093\/jn\/nxy319 (2019).","journal-title":"J. Nutr."},{"key":"88969_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13098-021-00674-z","volume":"13","author":"E Mokhtari","year":"2021","unstructured":"Mokhtari, E., Farhadnejad, H., Teymoori, F., Mirmiran, P. & Azizi, F. The association of insulinemic potential of diet and lifestyle with the risk of insulin-related disorders: a prospective cohort study among participants of Tehran lipid and glucose study. Diabetol. Metab. Syndr. 13, 53 (2021).","journal-title":"Diabetol. Metab. Syndr."},{"key":"88969_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12937-021-00697-2","volume":"20","author":"H Farhadnejad","year":"2021","unstructured":"Farhadnejad, H. et al. Association of the insulinemic potential of diet and lifestyle with risk of diabetes incident in Tehranian adults: a population based cohort study. Nutr. J. 20, 1\u201310 (2021).","journal-title":"Nutr. J."},{"key":"88969_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/liv.15057","volume":"42","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Higher dietary insulinaemic potential is associated with increased risk of liver steatosis and fibrosis. Liver Int. 42, 69\u201379. https:\/\/doi.org\/10.1111\/liv.15057 (2022).","journal-title":"Liver Int."},{"key":"88969_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/jhn.12865","volume":"34","author":"MH Sohouli","year":"2021","unstructured":"Sohouli, M. H. et al. Association of dietary insulinaemic potential and odds of non-alcoholic fatty liver disease among adults: a case-control study. J. Hum. Nutr. Diet. 34, 901\u2013909. https:\/\/doi.org\/10.1111\/jhn.12865 (2021).","journal-title":"J. Hum. Nutr. Diet."},{"key":"88969_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40795-023-00675-3","volume":"9","author":"A Momeni","year":"2023","unstructured":"Momeni, A., Haghshenas, R. & Jahromi, S. R. The association of dietary and lifestyle indices for hyperinsulinemia with odds of non-alcoholic fatty liver disease in Iranian adults: a case-control study. BMC Nutr. 9, 16. https:\/\/doi.org\/10.1186\/s40795-023-00675-3 (2023).","journal-title":"BMC Nutr."},{"key":"88969_CR26","unstructured":"Organization, W. H. WHO Child Growth Standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and Development (World Health Organization, 2006)."},{"key":"88969_CR27","unstructured":"Intakes, S. et al. Dietary Reference Intakes for Energy, Carbohydrate, fiber, fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. (National Academies, 2005)."},{"key":"88969_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.44.235.291","volume":"44","author":"WA Marshall","year":"1969","unstructured":"Marshall, W. A. & Tanner, J. M. Variations in pattern of pubertal changes in girls. Arch. Dis. Child. 44, 291 (1969).","journal-title":"Arch. Dis. Child."},{"key":"88969_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/adc.45.239.13","volume":"45","author":"WA Marshall","year":"1970","unstructured":"Marshall, W. A. & Tanner, J. M. Variations in the pattern of pubertal changes in boys. Arch. Dis. Child. 45, 13\u201323 (1970).","journal-title":"Arch. Dis. Child."},{"key":"88969_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2008-7802.151433","volume":"6","author":"M Delshad","year":"2015","unstructured":"Delshad, M. et al. Reliability and validity of the modifiable activity questionnaire for an Iranian urban adolescent population. Int. J. Prev. Med. 6, 3 (2015).","journal-title":"Int. J. Prev. Med."},{"key":"88969_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/clinchem\/36.1.15","volume":"36","author":"GR Warnick","year":"1990","unstructured":"Warnick, G. R., Knopp, R. H., Fitzpatrick, V. & Branson, L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin. Chem. 36, 15\u201319 (1990).","journal-title":"Clin. Chem."},{"key":"88969_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1017\/S0007114511006313","volume":"108","author":"G Asghari","year":"2012","unstructured":"Asghari, G. et al. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran lipid and glucose study. Br. J. Nutr. 108, 1109\u20131117 (2012).","journal-title":"Br. J. Nutr."},{"key":"88969_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2188\/jea.JE20090083","volume":"20","author":"FH Esfahani","year":"2010","unstructured":"Esfahani, F. H., Asghari, G., Mirmiran, P. & Azizi, F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran lipid and glucose study. J. Epidemiol. 20, 150\u2013158 (2010).","journal-title":"J. Epidemiol."},{"key":"88969_CR34","doi-asserted-by":"publisher","first-page":"1159664","DOI":"10.3389\/fcdhc.2023.1159664","volume":"4","author":"RA Vaidya","year":"2023","unstructured":"Vaidya, R. A. et al. Hyperinsulinemia: an early biomarker of metabolic dysfunction. Front. Clin. Diabetes Healthc. 4, 1159664. https:\/\/doi.org\/10.3389\/fcdhc.2023.1159664 (2023).","journal-title":"Front. Clin. Diabetes Healthc."},{"key":"88969_CR35","doi-asserted-by":"publisher","first-page":"E616","DOI":"10.1152\/ajpendo.00294.2023","volume":"326","author":"T Gignac","year":"2024","unstructured":"Gignac, T. et al. Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations. Am. J. Physiol. Endocrinol. Metab. 326, E616\u2013e625. https:\/\/doi.org\/10.1152\/ajpendo.00294.2023 (2024).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"88969_CR36","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s10620-024-08309-9","volume":"69","author":"ME Khamseh","year":"2024","unstructured":"Khamseh, M. E. et al. Insulin Resistance\/Sensitivity measures as screening indicators of metabolic-Associated fatty liver disease and liver fibrosis. Dig. Dis. Sci. 69, 1430\u20131443. https:\/\/doi.org\/10.1007\/s10620-024-08309-9 (2024).","journal-title":"Dig. Dis. Sci."},{"key":"88969_CR37","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.3390\/cimb45110570","volume":"45","author":"M Veskovi\u0107","year":"2023","unstructured":"Veskovi\u0107, M. et al. The interconnection between Hepatic Insulin Resistance and metabolic dysfunction-Associated Steatotic Liver Disease-the transition from an Adipocentric to Liver-Centric Approach. Curr. Issues Mol. Biol. 45, 9084\u20139102. https:\/\/doi.org\/10.3390\/cimb45110570 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"88969_CR38","doi-asserted-by":"publisher","first-page":"1604371","DOI":"10.3389\/ijph.2021.1604371","volume":"66","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese children and adolescents: systematic review and meta-analysis. Int. J. Public. Health. 66, 1604371 (2021).","journal-title":"Int. J. Public Health"},{"key":"88969_CR39","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.5114\/aoms.2018.79001","volume":"14","author":"M Mazidi","year":"2018","unstructured":"Mazidi, M., Banach, M., Kengne, A. P., Group, B. P. & Lipid & M.-a. C. Prevalence of childhood and adolescent overweight and obesity in Asian countries: a systematic review and meta-analysis. Archives Med. Sci. 14, 1185\u20131203 (2018).","journal-title":"Archives Med. Sci."},{"key":"88969_CR40","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/obr.12904","volume":"20","author":"V Sharma","year":"2019","unstructured":"Sharma, V. et al. A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years. Obes. Rev. 20, 1341\u20131349 (2019).","journal-title":"Obes. Rev."},{"key":"88969_CR41","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1210\/js.2019-00065","volume":"3","author":"DD Thomas","year":"2019","unstructured":"Thomas, D. D., Corkey, B. E., Istfan, N. W. & Apovian, C. M. Hyperinsulinemia: An Early Indicator of metabolic dysfunction. J. Endocr. Soc. 3, 1727\u20131747. https:\/\/doi.org\/10.1210\/js.2019-00065 (2019).","journal-title":"J. Endocr. Soc."},{"key":"88969_CR42","doi-asserted-by":"publisher","first-page":"36270","DOI":"10.1038\/srep36270","volume":"6","author":"JCY Ling","year":"2016","unstructured":"Ling, J. C. Y. et al. Determinants of high fasting insulin and insulin resistance among Overweight\/Obese adolescents. Sci. Rep. 6, 36270. https:\/\/doi.org\/10.1038\/srep36270 (2016).","journal-title":"Sci. Rep."},{"key":"88969_CR43","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1172\/JCI119628","volume":"100","author":"E Ferrannini","year":"1997","unstructured":"Ferrannini, E. et al. Insulin resistance and hypersecretion in obesity. J. Clin. Investig. 100, 1166\u20131173 (1997).","journal-title":"J. Clin. Investig."},{"key":"88969_CR44","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.3390\/nu15153350","volume":"15","author":"P Sandel","year":"2023","unstructured":"Sandel, P., Ma, L., Wang, H. & Pasman, E. A. You are what you eat: a review on dietary interventions for treating Pediatric nonalcoholic fatty liver disease. Nutrients 15, 3350 (2023).","journal-title":"Nutrients"},{"key":"88969_CR45","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/advances\/nmac077","volume":"13","author":"R Balakrishna","year":"2022","unstructured":"Balakrishna, R., Bj\u00f8rnerud, T., Bemanian, M., Aune, D. & Fadnes, L. T. Consumption of nuts and seeds and health outcomes including cardiovascular disease, diabetes and metabolic disease, cancer, and mortality: an umbrella review. Adv. Nutr. 13, 2136\u20132148 (2022).","journal-title":"Adv. Nutr."},{"key":"88969_CR46","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/nu9111271","volume":"9","author":"Y Kim","year":"2017","unstructured":"Kim, Y., Keogh, J. B. & Clifton, P. M. Benefits of nut consumption on insulin resistance and cardiovascular risk factors: multiple potential mechanisms of actions. Nutrients 9, 1271 (2017).","journal-title":"Nutrients"},{"key":"88969_CR47","doi-asserted-by":"publisher","first-page":"S437","DOI":"10.1093\/advances\/nmz003","volume":"10","author":"N Becerra-Tom\u00e1s","year":"2019","unstructured":"Becerra-Tom\u00e1s, N., Papandreou, C. & Salas-Salvad\u00f3, J. Legume consumption and cardiometabolic health. Adv. Nutr. 10, S437\u2013S450 (2019).","journal-title":"Adv. Nutr."},{"key":"88969_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12937-020-00631-y","volume":"19","author":"H Rahimi","year":"2020","unstructured":"Rahimi, H. et al. Dietary approaches to stop hypertension (DASH) score and obesity phenotypes in children and adolescents. Nutr. J. 19, 112. https:\/\/doi.org\/10.1186\/s12937-020-00631-y (2020).","journal-title":"Nutr. J."},{"key":"88969_CR49","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1038\/s41598-023-32961-2","volume":"13","author":"H Heshmatipour","year":"2023","unstructured":"Heshmatipour, H. et al. Association of legumes and nuts consumption with metabolic health status in Iranian overweight and obese adolescents. Sci. Rep. 13, 5784. https:\/\/doi.org\/10.1038\/s41598-023-32961-2 (2023).","journal-title":"Sci. Rep."},{"key":"88969_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","volume":"7","author":"N Stefan","year":"2019","unstructured":"Stefan, N., H\u00e4ring, H. U. & Cusi, K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 7, 313\u2013324 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"88969_CR51","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69, 1691\u20131705 (2020).","journal-title":"Gut"},{"key":"88969_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/s2468-1253(20)30090-x","volume":"5","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Fan, J. G. & Mendez-Sanchez, N. Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health. Lancet Gastroenterol. Hepatol. 5, 713\u2013715. https:\/\/doi.org\/10.1016\/s2468-1253(20)30090-x (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"88969_CR53","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739\u2013752 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"88969_CR54","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/s2468-1253(21)00132-1","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam, M. et al. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. Lancet Gastroenterol. Hepatol. 6, 743\u2013753. https:\/\/doi.org\/10.1016\/s2468-1253(21)00132-1 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"88969_CR55","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1111\/dom.15713","volume":"26","author":"C Pelekanou","year":"2024","unstructured":"Pelekanou, C. et al. Physical activity in relation to metabolic health and obesity: the Feel4Diabetes study. Diabetes Obes. Metab. 26, 3705\u20133714. https:\/\/doi.org\/10.1111\/dom.15713 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"88969_CR56","doi-asserted-by":"publisher","first-page":"E439","DOI":"10.1002\/oby.20135","volume":"21","author":"IJ Neeland","year":"2013","unstructured":"Neeland, I. J. et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obes. (Silver Spring). 21, E439\u2013447. https:\/\/doi.org\/10.1002\/oby.20135 (2013).","journal-title":"Obes. (Silver Spring)"},{"key":"88969_CR57","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/nutrit\/nuad122","volume":"82","author":"G Fiore","year":"2024","unstructured":"Fiore, G. et al. Chrononutrition and metabolic health in children and adolescents: a systematic review and meta-analysis. Nutr. Rev. 82, 1309\u20131354 (2024).","journal-title":"Nutr. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88969-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:15:51Z","timestamp":1738818951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88969-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88969"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88969-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol of this study was approved by the ethics committee of the Shahid Beheshti University of Medical Sciences. Written informed consents were obtained from participants\u2019 parents or legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"4465"}}